PhysioWizard wins the first Medicity Scotland Develop accelerator programme

PhysioWizard wins the first Medicity Scotland Develop accelerator programme

Medtech start-up PhysioWizard has become the first MediCity Scotland Develop Accelerator Programme winner, winning six months’ free tenancy, one to one business coaching and access to an international mentoring network.

The 12-week programme is delivered by MediCity Scotland through a partnership approach with the Glasgow City Region, North Lanarkshire Council, Scottish Enterprise and BioCity Scotland Limited.

It provides companies in the medtech, digital health and wellbeing sectors with intensive support from a network of expert coaches in the industry.

The coaches work with participants to challenge and test ideas for new products and services before designing a business model which then has a greater chance of success before raising investment.

PhysioWizard, which was founded by chartered physiotherapist Kirsten Lord in Edinburgh, is the world’s first clinically validated online self-assessment platform to treat back pain.

Kirsten said: “I was thrilled to be recognised by the independent and distinguished judges at the end of the Develop programme against fellow cohort participants who proved to be extremely stiff competition.

“I’m very excited about the business being engaged with MediCity Scotland where we can benefit and grow from the extensive support on offer and the close proximity to like-minded organisations.”

Toby Reid, Managing Director of BioCity said: “Everyone who has completed the programme also then has the scope to be considered for further one-to-one coaching, tenancy to the MediCity Scotland incubator, an investment readiness programme and access to our extensive Life Science Mentor Network, which are all an invaluable source of support.

“I’m very pleased to welcome PhysioWizard to MediCity Scotland and look forward to continuing our one-to-one support and mentorship as this innovative company takes its next steps.

“Life science businesses based at the BioCity Nottingham have had a 91% survival rate over the last 12 years, which clearly demonstrates the benefits that clustering similar businesses together in a supportive environment can bring.”